FENNEC PHARMACEUTICALS INC. Annual Return On Equity in % from 2011 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Fennec Pharmaceuticals Inc. quarterly/annual Return On Equity history and growth rate from 2011 to 2023.
  • Fennec Pharmaceuticals Inc. Return On Equity for the quarter ending September 30, 2024 was 29.9 %, a 88.8% decline year-over-year.
  • Fennec Pharmaceuticals Inc. annual Return On Equity for 2023 was 164 %.
  • Fennec Pharmaceuticals Inc. annual Return On Equity for 2022 was -445 %, a 426% decline from 2021.
  • Fennec Pharmaceuticals Inc. annual Return On Equity for 2021 was -84.6 %, a 22.5% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 164 +609 Jan 1, 2023 Dec 31, 2023
2022 -445 -361 -426% Jan 1, 2022 Dec 31, 2022
2021 -84.6 -15.5 -22.5% Jan 1, 2021 Dec 31, 2021
2020 -69.1 +12.6 +15.4% Jan 1, 2020 Dec 31, 2020
2019 -81.7 -39.9 -95.5% Jan 1, 2019 Dec 31, 2019
2018 -41.8 +16.8 +28.6% Jan 1, 2018 Dec 31, 2018
2017 -58.5 +29.4 +33.4% Jan 1, 2017 Dec 31, 2017
2016 -87.9 -12.7 -16.9% Jan 1, 2016 Dec 31, 2016
2015 -75.2 -150 -200% Jan 1, 2015 Dec 31, 2015
2014 75 +118 Jan 1, 2014 Dec 31, 2014
2013 -43.2 +2.09K +98% Jan 1, 2013 Dec 31, 2013
2012 -2.14K -1.74K -442% Jan 1, 2012 Dec 31, 2012
2011 -394 Jan 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.